Diagnostics giant Roche is putting its weight behind a biomarker for Alzheimer’s disease developed by ALZpath. The Swiss group has taken a license to use an antibody developed by ALZpath against a ...
fernando benetti NeuroCODE - Neurophysiology of Cognition & CNS Development Laboratory, Department of Physiology, Institute of Basic and Health Science (ICBS), Federal University of Rio Grande do Sul ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results